HK Stock MarketDetailed Quotes

06660 AIM VACCINE

Watchlist
  • 8.130
  • +0.120+1.50%
Market Closed Mar 28 16:08 CST
9.85BMarket Cap-6860P/E (TTM)

AIM VACCINE Key Stats

All
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q6)Jun 30, 2023
(FY)Dec 31, 2022
(Q6)Jun 30, 2022
(FY)Dec 31, 2021
(Q6)Jun 30, 2021
(FY)Dec 31, 2020
(Q6)Jun 30, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
Turnover
-6.06%1.19B
-8.64%540.47M
-19.49%1.26B
-12.04%591.57M
-4.14%1.57B
26.53%672.56M
72.12%1.64B
--531.56M
-14.36%951.65M
--1.11B
Operating income
-6.06%1.19B
-8.64%540.47M
-19.49%1.26B
-12.04%591.57M
-4.14%1.57B
26.53%672.56M
72.12%1.64B
531.56M
-14.36%951.65M
1.11B
Cost of sales
-21.17%-286.45M
1.93%-107.82M
14.17%-236.41M
11.39%-109.94M
2.98%-275.43M
-16.74%-124.08M
-29.74%-283.88M
---106.29M
10.69%-218.8M
---244.98M
Operating expenses
-21.17%-286.45M
1.93%-107.82M
14.17%-236.41M
11.39%-109.94M
2.98%-275.43M
-16.74%-124.08M
-29.74%-283.88M
-106.29M
10.69%-218.8M
-244.98M
Gross profit
-12.32%901.02M
-10.17%432.65M
-20.63%1.03B
-12.19%481.63M
-4.39%1.29B
28.97%548.48M
84.77%1.35B
425.27M
-15.39%732.85M
866.19M
Selling expenses
-0.17%-494M
3.48%-224.9M
-7.18%-493.17M
-1.82%-233M
13.71%-460.11M
-29.33%-228.83M
-61.59%-533.25M
---176.94M
30.48%-330.01M
---474.71M
Administrative expenses
43.59%-254.29M
37.67%-115.66M
61.41%-450.76M
81.91%-185.57M
-487.82%-1.17B
-1,049.55%-1.03B
-26.41%-198.7M
---89.23M
16.48%-157.18M
---188.19M
Research and development expenses
-27.20%-636.4M
-105.40%-398.53M
-62.78%-500.31M
-38.98%-194.03M
-94.82%-307.35M
-202.11%-139.61M
-59.54%-157.76M
---46.21M
-76.10%-98.89M
---56.15M
Impairment and provision
-6,473.38%-1.79B
44.68%-3.67M
-241.00%-27.22M
-165.89%-6.63M
-866.22%-7.98M
-64.36%-2.5M
-139.28%-826K
---1.52M
117.82%2.1M
---11.8M
-Impairment of intangible assets
---1.51B
----
----
----
----
----
----
----
----
----
-Impairment of property, machinery and equipment
---61.09M
----
----
----
----
----
----
----
----
----
-Goodwill impairment
---211.44M
----
----
----
----
----
----
----
----
----
-Other impairment is provision
84.64%-4.18M
44.68%-3.67M
-241.00%-27.22M
-165.89%-6.63M
-866.22%-7.98M
-64.36%-2.5M
-139.28%-826K
---1.52M
117.82%2.1M
---11.8M
Special items of operating profit
29.69%45.8M
24.84%19.39M
-33.02%35.32M
-38.09%15.53M
38.49%52.73M
126.16%25.09M
103.92%38.07M
--11.09M
50.19%18.67M
--12.43M
Operating profit
-445.16%-2.23B
-138.14%-290.72M
31.46%-408.47M
85.17%-122.08M
-218.81%-596M
-772.10%-823.11M
199.40%501.63M
122.47M
13.38%167.54M
147.77M
Financing cost
-70.60%-43.83M
-87.23%-19.16M
-140.05%-25.69M
-88.97%-10.23M
32.01%-10.7M
46.05%-5.41M
-46.01%-15.74M
---10.04M
-47.28%-10.78M
---7.32M
Earning before tax
-422.99%-2.27B
-134.21%-309.88M
28.44%-434.17M
84.03%-132.31M
-224.87%-606.7M
-836.91%-828.53M
209.95%485.89M
112.43M
11.61%156.76M
140.45M
Tax
57.42%320.4M
-71.38%52.45M
394.25%203.54M
627.13%183.26M
19.07%-69.17M
-45.23%-34.77M
-131.34%-85.47M
---23.94M
5.34%-36.95M
---39.03M
After-tax profit from continuing operations
-745.61%-1.95B
-605.30%-257.43M
65.88%-230.63M
105.90%50.95M
-268.79%-675.87M
-1,075.54%-863.29M
234.20%400.41M
88.49M
18.14%119.81M
101.42M
Earning after tax
-745.61%-1.95B
-605.30%-257.43M
65.88%-230.63M
105.90%50.95M
-268.79%-675.87M
-1,075.54%-863.29M
234.20%400.41M
88.49M
18.14%119.81M
101.42M
Minority profit
-829.72%-649.24M
-107.37%-7.06M
426.42%88.97M
6,735.94%95.82M
-20.00%16.9M
-130.54%-1.44M
777.37%21.13M
--4.73M
-97.34%2.41M
--90.37M
Profit attributable to shareholders
-307.07%-1.3B
-457.90%-250.37M
53.87%-319.6M
94.79%-44.88M
-282.65%-692.77M
-1,128.88%-861.85M
223.06%379.29M
83.77M
962.11%117.41M
11.05M
Basic earnings per share
-296.30%-1.07
-425.00%-0.21
55.00%-0.27
94.81%-0.04
-253.85%-0.6
-955.56%-0.77
178.57%0.39
0.09
1,300.00%0.14
0.01
Diluted earnings per share
-296.30%-1.07
-425.00%-0.21
55.00%-0.27
94.81%-0.04
-253.85%-0.6
-955.56%-0.77
178.57%0.39
0.09
1,300.00%0.14
0.01
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
IAS
Audit Opinions
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
--
Unqualified Opinion
Unqualified Opinion
Auditor
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
--
Ernst & Young
Ernst & Young
(FY)Dec 31, 2023(Q6)Jun 30, 2023(FY)Dec 31, 2022(Q6)Jun 30, 2022(FY)Dec 31, 2021(Q6)Jun 30, 2021(FY)Dec 31, 2020(Q6)Jun 30, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018
Turnover -6.06%1.19B-8.64%540.47M-19.49%1.26B-12.04%591.57M-4.14%1.57B26.53%672.56M72.12%1.64B--531.56M-14.36%951.65M--1.11B
Operating income -6.06%1.19B-8.64%540.47M-19.49%1.26B-12.04%591.57M-4.14%1.57B26.53%672.56M72.12%1.64B531.56M-14.36%951.65M1.11B
Cost of sales -21.17%-286.45M1.93%-107.82M14.17%-236.41M11.39%-109.94M2.98%-275.43M-16.74%-124.08M-29.74%-283.88M---106.29M10.69%-218.8M---244.98M
Operating expenses -21.17%-286.45M1.93%-107.82M14.17%-236.41M11.39%-109.94M2.98%-275.43M-16.74%-124.08M-29.74%-283.88M-106.29M10.69%-218.8M-244.98M
Gross profit -12.32%901.02M-10.17%432.65M-20.63%1.03B-12.19%481.63M-4.39%1.29B28.97%548.48M84.77%1.35B425.27M-15.39%732.85M866.19M
Selling expenses -0.17%-494M3.48%-224.9M-7.18%-493.17M-1.82%-233M13.71%-460.11M-29.33%-228.83M-61.59%-533.25M---176.94M30.48%-330.01M---474.71M
Administrative expenses 43.59%-254.29M37.67%-115.66M61.41%-450.76M81.91%-185.57M-487.82%-1.17B-1,049.55%-1.03B-26.41%-198.7M---89.23M16.48%-157.18M---188.19M
Research and development expenses -27.20%-636.4M-105.40%-398.53M-62.78%-500.31M-38.98%-194.03M-94.82%-307.35M-202.11%-139.61M-59.54%-157.76M---46.21M-76.10%-98.89M---56.15M
Impairment and provision -6,473.38%-1.79B44.68%-3.67M-241.00%-27.22M-165.89%-6.63M-866.22%-7.98M-64.36%-2.5M-139.28%-826K---1.52M117.82%2.1M---11.8M
-Impairment of intangible assets ---1.51B------------------------------------
-Impairment of property, machinery and equipment ---61.09M------------------------------------
-Goodwill impairment ---211.44M------------------------------------
-Other impairment is provision 84.64%-4.18M44.68%-3.67M-241.00%-27.22M-165.89%-6.63M-866.22%-7.98M-64.36%-2.5M-139.28%-826K---1.52M117.82%2.1M---11.8M
Special items of operating profit 29.69%45.8M24.84%19.39M-33.02%35.32M-38.09%15.53M38.49%52.73M126.16%25.09M103.92%38.07M--11.09M50.19%18.67M--12.43M
Operating profit -445.16%-2.23B-138.14%-290.72M31.46%-408.47M85.17%-122.08M-218.81%-596M-772.10%-823.11M199.40%501.63M122.47M13.38%167.54M147.77M
Financing cost -70.60%-43.83M-87.23%-19.16M-140.05%-25.69M-88.97%-10.23M32.01%-10.7M46.05%-5.41M-46.01%-15.74M---10.04M-47.28%-10.78M---7.32M
Earning before tax -422.99%-2.27B-134.21%-309.88M28.44%-434.17M84.03%-132.31M-224.87%-606.7M-836.91%-828.53M209.95%485.89M112.43M11.61%156.76M140.45M
Tax 57.42%320.4M-71.38%52.45M394.25%203.54M627.13%183.26M19.07%-69.17M-45.23%-34.77M-131.34%-85.47M---23.94M5.34%-36.95M---39.03M
After-tax profit from continuing operations -745.61%-1.95B-605.30%-257.43M65.88%-230.63M105.90%50.95M-268.79%-675.87M-1,075.54%-863.29M234.20%400.41M88.49M18.14%119.81M101.42M
Earning after tax -745.61%-1.95B-605.30%-257.43M65.88%-230.63M105.90%50.95M-268.79%-675.87M-1,075.54%-863.29M234.20%400.41M88.49M18.14%119.81M101.42M
Minority profit -829.72%-649.24M-107.37%-7.06M426.42%88.97M6,735.94%95.82M-20.00%16.9M-130.54%-1.44M777.37%21.13M--4.73M-97.34%2.41M--90.37M
Profit attributable to shareholders -307.07%-1.3B-457.90%-250.37M53.87%-319.6M94.79%-44.88M-282.65%-692.77M-1,128.88%-861.85M223.06%379.29M83.77M962.11%117.41M11.05M
Basic earnings per share -296.30%-1.07-425.00%-0.2155.00%-0.2794.81%-0.04-253.85%-0.6-955.56%-0.77178.57%0.390.091,300.00%0.140.01
Diluted earnings per share -296.30%-1.07-425.00%-0.2155.00%-0.2794.81%-0.04-253.85%-0.6-955.56%-0.77178.57%0.390.091,300.00%0.140.01
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards IASIASIASIASIASIASIASIASIASIAS
Audit Opinions Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified Opinion--Unqualified OpinionUnqualified Opinion
Auditor Ernst & Young--Ernst & Young--Ernst & Young--Ernst & Young--Ernst & YoungErnst & Young

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
HK
Overall
Symbol
Latest Price
%Chg